Land: Armenien
Språk: engelska
Källa: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
benzylpenicillin (benzylpenicillin sodium)
Reyoung Pharmaceutical Co. Ltd.
J01CE01
benzylpenicillin (benzylpenicillin sodium)
1000000IU
powder for solution for injection
(50) glass vial
Prescription
Registered
2016-03-16
_Instructions on the medicinal use of the drug for doctors and consumers. _ PENICILLIN-G RS BENZYLPENICILLIN SODIUM EQ. TO BENZYLPENICILLIN 1,000,000 IU POWDER FOR INJECTION 1 MEGA PHARMACEUTICAL FORM : POWDER FOR INJECTION . The preparation is a white sterile crystalline powder, which is very soluble in water. And has a property of moisture absorption it rapidly lose its activity toward, acids, alkalies or oxidizer. COMPOSITION: Each vial contains: Benzylpenicillin Sodium eq. to Benzylpenicillin 1,000,000 IU PHARMACEUTICAL GROUP: Beta-lactamase sensitive penicillins. ATC CODE: J01CE01 INDICATIONS AND USAGE FOR PENICILLIN-G RS THERAPY Benzylpenicillin Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to Benzylpenicillin. Therapy with Benzylpenicillin Injection may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once these results become available, appropriate therapy should be continued. CLINICAL INDICATION INFECTING ORGANISM Septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis Streptococcus pyogenes (group A β-hemolytic streptococcus), other β-hemolytic streptococci including groups C, H, G, L and M, Streptococcus pneumoniae and Staphylococcus species (non-penicillinase producing strains) Anthrax Bacillus anthracis Actinomycosis (cervico-facial disease and thoracic and abdominal disease) Actinomyces israelii Botulism (adjunctive therapy to antitoxin), gas gangrene, and tetanus (adjunctive therapy to human tetanus immune globulin) Clostridium species Diphtheria (adjunctive therapy to antitoxin and prevention of the carrier state) Corynebacterium diphtheriae Erysipelothrix endocarditis Erysipelothrix rhusiopathia Läs hela dokumentet
Appendix 1.9 PENICILLIN-G RS BENZYLPENICILLIN SODIUM EQ. TO BENZYLPENICILLIN 1,000,000 IU POWDER FOR INJECTION 1 MEGA THE SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PENICILLIN-G RS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION WITH INDICATION OF ACTIVE SUBSTANCES (INTERNATIONAL NONPROPRIETARY NAME OR CHEMICAL NAME), INDICATION OF OTHER EXCIPIENTS KNOWLEDGE OF WHICH IS ESSENTIAL FOR SAFE AND PROPER ADMINISTRATION OF THE MEDICINAL PRODUCT. Each vial contains: Benzylpenicillin Sodium eq. to Benzylpenicillin 1,000,000 IU 3. PHARMACEUTICAL FORM: Powder for injection. The preparation is a white sterile crystalline powder, which is very soluble in water. And has a property of moisture absorption it rapidly lose its activity toward, acids, alkalies or oxidizer. PHARMACEUTICAL GROUP: Beta-lactamase sensitive penicillins. ATC CODE: J01CE01 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Benzylpenicillin Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to Benzylpenicillin. Therapy with Benzylpenicillin Injection may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once these results become available, appropriate therapy should be continued. CLINICAL INDICATION INFECTING ORGANISM Septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis Streptococcus pyogenes (group A β- hemolytic streptococcus), other β-hemolytic streptococci including groups C, H, G, L and M, Streptococcus pneumoniae and Staphylococcus species (non-penicillinase producing strains) Anthrax Bacillus anthracis Actinomycosis (cervico-facial disease and thoracic and abdominal disease) Actinomyces israelii Botulism (adjunctive therapy Läs hela dokumentet